Amino acid boosts cancer treatment? new study tests leucine combo
NCT ID NCT07359989
Summary
This study is testing if adding a common amino acid called leucine to the standard pre-surgery treatment (chemotherapy and radiation) can help shrink tumors more effectively in people with locally advanced rectal cancer. The goal is to see if this combination leads to better outcomes, like having no cancer cells left after surgery. It will enroll about 33 patients to check both safety and how well the treatment works.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Second Affiliated Hospital Of Zhejiang University School of Medicine
RECRUITINGHangzhou, Zhejiang, 310009, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.